IMV Updates Rapid Progress on COVID-19 Vaccine Program
-Received agreement with Health Canada on Phase 1 clinical study design protocol which also includes older patients of 56 years and above
-Completed cGMP formulation and manufacturing process development for clinical trials
-Ready and prepared for Clinical Trial Application submission for regulatory approval
"Next milestones are anticipated as we commence phase 1 clinical trials this summer with results in the Fall of 2020. Once results are published, we plan to initiate phase 2 clinical trials in the second half of the year."
www.imv-inc.com/inve...d-19-vaccine-program
finance.yahoo.com/ne...arket-130158025.html
-Received agreement with Health Canada on Phase 1 clinical study design protocol which also includes older patients of 56 years and above
-Completed cGMP formulation and manufacturing process development for clinical trials
-Ready and prepared for Clinical Trial Application submission for regulatory approval
"Next milestones are anticipated as we commence phase 1 clinical trials this summer with results in the Fall of 2020. Once results are published, we plan to initiate phase 2 clinical trials in the second half of the year."
www.imv-inc.com/inve...d-19-vaccine-program
finance.yahoo.com/ne...arket-130158025.html